Pulmonary Artery Endovascular Device Compensates for Loss of Vascular Compliance in Pulmonary Arterial Hypertension

Christian Gerges; Karl Vollmers; Marc R. Pritzker; John Gainor; John Scandurra; Edward K Weir; Irene M. Lang

doi:10.1016/j.jacc.2020.08.080

Pulmonary Artery Endovascular Device Compensates for Loss of Vascular Compliance in Pulmonary Arterial Hypertension

Christian Gerges, Karl Vollmers, Marc R. Pritzker, John Gainor, John Scandurra, Edward K Weir, Irene M. Lang

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2284-2286
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	76
Issue number	19
DOIs	https://doi.org/10.1016/j.jacc.2020.08.080
State	Published - Nov 10 2020

Bibliographical note

Funding Information:
This research was funded by Aria CV. Dr. Gerges has received compensation for scientific symposia from AOPOrphan Pharmaceuticals, Actelion, and GlaxoSmithKline. Dr. Vollmers is the chief technology officer at Aria CV. Drs. Pritzker and Weir serve on the Aria CV scientific advisory board. Mr. Gainor is a consultant for Aria CV. Dr. Scandurra is the chief scientific officer at Aria CV. Dr. Lang has been an investigator in trials for, a consultant for, received research grants from, and been a member of scientific advisory boards for AOPOrphan Pharmaceuticals, Actelion, Merck Sharp & Dohme, AstraZeneca, Medtronic, Ferrer, and United Therapeutics. The authors thank the nurses and technicians of the cardiac catheterization laboratory of the Medical University of Vienna for their support throughout the study.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.jacc.2020.08.080

OpenUrl availability

Full text

Cite this

@article{e96a4126da9e47b3870bab5a7ca3a2c1,

title = "Pulmonary Artery Endovascular Device Compensates for Loss of Vascular Compliance in Pulmonary Arterial Hypertension",

author = "Christian Gerges and Karl Vollmers and Pritzker, {Marc R.} and John Gainor and John Scandurra and Weir, {Edward K} and Lang, {Irene M.}",

note = "Funding Information: This research was funded by Aria CV. Dr. Gerges has received compensation for scientific symposia from AOPOrphan Pharmaceuticals, Actelion, and GlaxoSmithKline. Dr. Vollmers is the chief technology officer at Aria CV. Drs. Pritzker and Weir serve on the Aria CV scientific advisory board. Mr. Gainor is a consultant for Aria CV. Dr. Scandurra is the chief scientific officer at Aria CV. Dr. Lang has been an investigator in trials for, a consultant for, received research grants from, and been a member of scientific advisory boards for AOPOrphan Pharmaceuticals, Actelion, Merck Sharp & Dohme, AstraZeneca, Medtronic, Ferrer, and United Therapeutics. The authors thank the nurses and technicians of the cardiac catheterization laboratory of the Medical University of Vienna for their support throughout the study.",

year = "2020",

month = nov,

day = "10",

doi = "10.1016/j.jacc.2020.08.080",

language = "English (US)",

volume = "76",

pages = "2284--2286",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "19",

}

TY - JOUR

T1 - Pulmonary Artery Endovascular Device Compensates for Loss of Vascular Compliance in Pulmonary Arterial Hypertension

AU - Gerges, Christian

AU - Vollmers, Karl

AU - Pritzker, Marc R.

AU - Gainor, John

AU - Scandurra, John

AU - Weir, Edward K

AU - Lang, Irene M.

N1 - Funding Information: This research was funded by Aria CV. Dr. Gerges has received compensation for scientific symposia from AOPOrphan Pharmaceuticals, Actelion, and GlaxoSmithKline. Dr. Vollmers is the chief technology officer at Aria CV. Drs. Pritzker and Weir serve on the Aria CV scientific advisory board. Mr. Gainor is a consultant for Aria CV. Dr. Scandurra is the chief scientific officer at Aria CV. Dr. Lang has been an investigator in trials for, a consultant for, received research grants from, and been a member of scientific advisory boards for AOPOrphan Pharmaceuticals, Actelion, Merck Sharp & Dohme, AstraZeneca, Medtronic, Ferrer, and United Therapeutics. The authors thank the nurses and technicians of the cardiac catheterization laboratory of the Medical University of Vienna for their support throughout the study.

PY - 2020/11/10

Y1 - 2020/11/10

UR - http://www.scopus.com/inward/record.url?scp=85094570443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85094570443&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2020.08.080

DO - 10.1016/j.jacc.2020.08.080

M3 - Letter

C2 - 33153589

AN - SCOPUS:85094570443

SN - 0735-1097

VL - 76

SP - 2284

EP - 2286

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 19

ER -

Pulmonary Artery Endovascular Device Compensates for Loss of Vascular Compliance in Pulmonary Arterial Hypertension

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this